Diflucortolone valerate, isoconazole
Sold as Maxaderm, Travocort
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
Background
Registration
- Applicants
- 2
- Registrations
- 2
- Schedule source
- SAHPRA documentation
Applicants and registrations
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Maxaderm EACH 1,0 g CREAM CONTAINS DIFLUCORTOLONE VALERATE 1,0 mg ISOCONAZOLE NITRATE 10,0 mg | Not listed | 33030333/13.4.1/0303 | Registered | Not determined | None |
| Travocort EACH 1 g CREAM CONTAINS DIFLUCORTOLONE VALERATE 1 mg ISOCONAZOLE NITRATE 10 mg | 10 mg / 1 mgCream | N0171N/13.4.1/171Approved 9 May 2023 | Registered | S4 | PIPIL |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Diflucortolone valerate, isoconazole nitrate
S4: Diflucortolone
Consolidated Schedules 06 July 2026, line 6038
S4: Isoconazole
- except when intended for application to the skin and when intended for human vaginal use, specifically for the treatment of recurrent vaginal candidiasis. (S1)
Consolidated Schedules 06 July 2026, lines 6814 to 6815
S1: Isoconazole
- human vaginal use specifically for the treatment of recurrent vaginal candidiasis (S4); and
- application to the skin. (S4)
Consolidated Schedules 06 July 2026, lines 583 to 587
Pharmacological class: Corticosteroids with or without anti-infective agents. (class 13.4.1)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Travocort, Adcock ingram limited is scheduled S4 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.